March is World TB Month

TB is the number 1 killer of South Africans, even though it is curable. It is estimated that 6 - 10 million South Africans are infected with the TB virus. Click here for a collection of resources you can use in your organisation to educate your employees about TB.

Catalyzing partnerships to tackle
HIV/AIDS I Tuberculosis I Malaria  I Health Systems 

Source: http://www.weforum.org/en/initiatives/globalhealth/index.htm

The Global Health Initiative (GHI) was launched by Kofi Annan at the Annual Meeting 2002 in Davos. The GHI’s mission is to engage businesses in public-private partnerships to tackle HIV/AIDS, TB, Malaria and Health Systems.

New Toolkit to Boost South African Companies Response to TB Threat
The Global Health Initiative of the World Economic Forum with support from Lilly MDR-TB Partnership and inputs from key partners has developed a toolkit, Protecting Your Workforce from Tuberculosis: A Toolkit for an Integrated Approach to TB and HIV for Businesses in South Africa. It is especially designed to support South African companies plan and implement workplace and community-based TB control programmes. The toolkit launched on June 3 at the Africa Summit encourages companies to adopt an integrated approach to manage TB and HIV co-infections. Press Release
Toolkit 2 pager (PDF)
Preface and Introduction (PDF) I 10 Principles for Starting a Workplace Programme (PDF) I Contacts and References (PDF) I Fact Sheets for Health Professionals (PDF) I Fact Sheet for Employees (PDF) I Fact Sheet on Anti-discrimination (PDF) I Key Messages 
Poster 1 (PDF) I Poster 2 (PDF) I Poster 3 (PDF)
 

Latest Report - ‘Tackling Tuberculosis: The Business Response’

The Global Health Initiative (GHI) of the World Economic Forum has launched a report entitled “Tackling Tuberculosis: The Business Response” (PDF) which provides an overview of the threat posed by tuberculosis to the private sector and makes recommendations for the private sector in the global context.

The report is based on an analysis of responses to questions on TB in the World Economic Forum’s annual Executive Opinion Survey (EOS). The EOS forms part of the Forum’s annual Global Competitiveness Report, which is intended to assist business leaders and policy-makers in understanding the drivers of, and impediments to, competitiveness in their countries. The survey elicits the views on competitiveness of more than 11, 000 business leaders from 131 countries and has, since 2004, included questions on the perceived impact on the private sector of three major infectious diseases – HIV/AIDS, TB, and malaria.

• Key findings in the report:
• Nearly one-third of respondents to the 2007 Survey expect tuberculosis to affect their business in the next five years. One in ten expects the effects to be serious.
• Firms in sub-Saharan Africa, Asia, and Eastern Europe are most concerned. Concern has risen steeply in a handful of large countries, including India, Brazil, Turkey, Korea, and South Africa.
• Firms in poorer countries with high TB prevalence are particularly worried.
• Where HIV/AIDS and TB pose twin threats, the impact is expected to be greater still. In some sub-Saharan African countries, over 80% of respondent firms predict that TB will affect their business in the near future.
• While transmission of the disease can occur in workplaces, workforces offer a ready audience for TB education campaigns, and businesses have many skills that can help tackle health problems. There is strong potential, therefore, for businesses to help fight TB.
• Businesses have a variety of motivations for acting to control the disease, from limiting its impacts on employees to strengthening partnerships with other stakeholders to enhancing corporate reputation.
• Hundreds of firms from across the world have signed up to initiatives such as the Global Health Initiative of the World Economic Forum, the Stop TB Partnership and the Global Fund to Fight AIDS, Tuberculosis and Malaria – bodies that aim to harness business expertise and resources to tackle ill health, primarily in the developing world.
• A number of businesses are engaged in TB control efforts, based on their core competencies, in partnership with national governments, international organisations and other partners in the private sector; yet the momentum is not comparable to business action on HIV/AIDS.

The report was prepared by David E. Bloom, Clarence James Gamble Professor of Economics and Demography and Chairman of the Department of Population and International Health at the Harvard School of Public Health, with inputs from key experts from the GHI's Non-Executive Board and from the Stop TB Partnership.